Patents by Inventor Nancy A. Scott

Nancy A. Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230302349
    Abstract: A math game that requires choice and strategic thinking in the practice of multiplication. Play takes place on a game board which consists of a grid of randomly arranged multiplication products. Players are given a “hand” of three or more numbered cards, with each number representing a factor in a multiplication problem. Players take turns choosing two of the factors in their hand to create a product which they mark on the game board. The first player to obtain the required number of marked products in a row, horizontally, vertically, or diagonally, wins the game. By choosing which factors they multiply, players can make offensive or defensive moves in their attempt to be the first to mark the required number of products in a row.
    Type: Application
    Filed: March 23, 2022
    Publication date: September 28, 2023
    Inventor: Nancy Scott Field
  • Patent number: 11446310
    Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: September 20, 2022
    Assignee: Xeris Pharmaceuticals, Inc.
    Inventors: Steven J. Prestrelski, Nancy Scott
  • Publication number: 20200368250
    Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.
    Type: Application
    Filed: July 31, 2020
    Publication date: November 26, 2020
    Applicant: Xeris Pharmaceuticals, Inc.
    Inventors: Steven J. PRESTRELSKI, Nancy SCOTT
  • Patent number: 10765683
    Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.
    Type: Grant
    Filed: July 29, 2015
    Date of Patent: September 8, 2020
    Assignee: Xeris Pharmaceuticals, Inc.
    Inventors: Steven J. Prestrelski, Nancy Scott
  • Publication number: 20160151385
    Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.
    Type: Application
    Filed: July 29, 2015
    Publication date: June 2, 2016
    Inventors: Steven J. PRESTRELSKI, Nancy SCOTT
  • Patent number: 9125805
    Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: September 8, 2015
    Assignee: Xeris Pharmaceuticals, Inc.
    Inventors: Steven J. Prestrelski, Nancy Scott
  • Publication number: 20140349926
    Abstract: Disclosed is a formulation for parenteral administration comprising insulin that comprises a pH memory between 1 to 4 or between 6 to 8 and an aprotic polar solvent, wherein the insulin is solubilized in the aprotic polar solvent, wherein the solubilized insulin comprises stable monomeric or dimeric forms of insulin or mixtures thereof, and wherein the water content of the formulation is equal to or less than 15% w/v.
    Type: Application
    Filed: October 31, 2012
    Publication date: November 27, 2014
    Inventors: Steven Prestrelski, Nancy Scott
  • Publication number: 20140005135
    Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.
    Type: Application
    Filed: March 14, 2013
    Publication date: January 2, 2014
    Applicant: XERIS PHARMACEUTICALS, INC.
    Inventors: Steven J. Prestrelski, Nancy Scott
  • Patent number: 6948698
    Abstract: A valve for a pressurized canister includes a housing having a central aperture extending therethrough, a first set of external threads, and a second set of external threads. A sealing member is positioned in an axially outward end of the central aperture and is axially moveable. A first spring biases the pin axially outwardly. An axially slidable member is received and axially movable in the central aperture. A second spring biases the axially slidable member outwardly. A threaded member in an aperture in the housing engages the axially slidable member. Each of a plurality of radially moveable members is positioned in an aperture in the housing and is radially moveable between a lip on the aperture and the second spring. An exterior surface of an inner end of the axially slidable member engages and forces each radially moveable member into contact with the lip when the threaded member is tightened.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: September 27, 2005
    Inventors: Eric Scott, Nancy A. Scott